H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 413,066. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tulsa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tulsa storefront.
Fibrin Matrix Therapy Products in Tulsa, OK for clinics & physicians. Fibrin matrix therapy supports wound… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Tulsa is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Oklahoma is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for fibrin matrix therapy, not a walk-in clinic.
National Fibrin Matrix Therapy Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Tulsa we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure.
We are not going to invent a Tulsa warehouse or a five-star local review. What you get is fibrin matrix therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JH, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tulsa trial.
Regulatory lane, storage, and JH coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
If you operate in Oklahoma and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Tulsa tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Tulsa, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tulsa is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tulsa — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tulsa. Useful for joint-program math; still needs a diagnosis and privileging.
No Tulsa storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.